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Abstract 
Roux-en-Y gastric bypass (RYGB) surgery might modify the gut microbiota composition 
differently in the three distinct anatomical sections of small intestine compared to sham 
surgery. We showed that RYGB induced changes in the microbiota of the alimentary 
limb and the common channel resembling those seen after prebiotics treatment or 
weight loss by dieting. These changes may be associated with altered production of 
intestinal hormones known to control energy balance. Postsurgical modulation of gut 
microbiota may significantly contribute to the beneficial metabolic effects of RYGB 
surgery. 
 
Keywords: Gut microbiota; bariatric surgery; GLP-1 
 
1. Introduction 
Recent studies examined the association between changes in intestinal microbial 
diversity in obese rodents and humans; some bacterial groups were associated with 
changes in the nutritional status. Obesity was associated with higher Firmicutes and 
lower Bifidobacterium spp, Bacteroides-related bacteria and Lactobacillus spp in 
comparison with the lean counterparts [1-4]. Interestingly, weight loss achieved by 
dieting was able to reverse those changes [5]. Furthermore, nutrients with prebiotic 
properties induced qualitative changes in the composition of the gastrointestinal 
microbiota and peptide release (e.g., glucagon-like peptide-1 (GLP-1)) similar to those 
seen after dieting. In diet-induced obese and type 2 diabetic (T2DM) mice the release of 
gut peptides induced by treatment with prebiotics improved glucose and lipid metabolism 
as well as systemic inflammation [6].  
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Roux-en-Y gastric bypass (RYGB) is currently, the most effective strategy for long term 
weight loss maintenance. RYGB significantly reduces body weight, improves T2DM and 
changes the postprandial enteric endocrine responses.  
Gut microbiota analysis of fecal samples from humans and rats after RYGB suggested 
that the reduction of Firmicutes and Bacteroidetes may partly explain the weight loss 
and beneficial effects on metabolism and inflammation associated with the RYGB 
surgery [7-9]. Liou [10] et al. confirmed these findings and also showed that cecal 
transplants from mice after RYGB to unoperated germ free mice decreased body weight 
and adiposity compared to recipients of microbiota from sham-operated mice. 
There are currently no data on the impact of gut microbiota on the hormonal and 
metabolic changes associated with RYGB. In most of the human and rodent studies 
investigating the ecology and activity of intestinal microbiota, fecal or cecal samples 
have been used. However, these may not be representative of the microbiome in RYGB 
where the intestine is surgically manipulated into three discrete section which may each 
contribute to distinct metabolic signals compared to feces that represents a amalgamate 
of the microbiome from the intestine as a whole. Therefore, we assessed the bacterial 
composition in the different anatomically corresponding intestinal segments after RYGB 
or sham surgery. 
2. Materials and Methods 
2.1 Subjects and Housing 
Sixteen male Wistar rats (Harlan Laboratories Inc., Blackthorn, UK; Elevage Janvier, Le-
Genest-St. Isle, France) were individually housed under a 12 h /12 h light-dark cycle at a 
room temperature of 21 ± 2 ºC. Water and standard chow were available ad libitum. All 
experiments were approved by the Veterinary Office of the Canton Zurich, Switzerland. 
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All rats were given one week of acclimatization before being randomized to RYGB (n= 8) 
or sham-operation (n= 8). After surgery, rats received Ensure (chocolate Ensure Plus, 
Abbott Nutrition, Baar, Switzerland) for 3 days before access to normal chow was 
reinstalled. Body weight was measured weekly. A food restricted sham-operated group 
of rats (n= 7), whose postoperative weight matched the weight of bypass-treated 
animals, was also studied (data not shown; see also ref [11]); data were comparable to 
the sham-operated ad libitum fed controls except for one parameter (see below). 
2.2 Surgery 
Rats were allocated to either RYGB (N= 8, body weight, mean ± SEM, 445 ± 5 g) or 
sham-operated (sham, N= 8; 435 ± 5 g) surgery groups. Anesthesia was induced in a 
chamber filled with 5% isoflurane in oxygen (1 L/min). After an adequate depth of 
anesthesia was achieved, rats were shaved from sternum to pelvis followed by 
disinfection with Betadine scrub (Mundi Pharma, Basel, Switzerland). Rats were then 
placed in a supine position on a heating pad and positioned in a nose cone to maintain 
anesthesia (2%–4% isoflurane in oxygen, 0.5 L/min) for the duration of the surgery. All 
surgeries were conducted as previously described [11-13] and the small intestinal 
segments after RYGB (biliopancreatic limb; alimentary limb; common channel) are 
depicted in Figure 1. Briefly, a midline incision of approximately 4 cm starting just below 
the xiphoid process was performed. For the RYGB procedure, the small bowel was 
transected approximately 20 cm distal to the pylorus of the stomach, creating a proximal 
and distal end of small bowel. The proximal end, being still continuous with the 
remaining portion of the stomach, constituted the biliopancreatic limb and was 
anastomosed to the ileum approximately 25–30 cm from the cecum, creating the 
common channel. For formation of the gastric pouch, the stomach was transected 
7 
 
approximately 5 mm below the gastroesophageal junction, creating a gastric pouch of a 
size of no more than 2%–3% of original stomach size. The Roux-en-Y reconstruction 
was completed by connecting the distal end of the small bowel to the gastric pouch, 
leading to formation of the alimentary limb. One single RYGB procedure lasted 
approximately 70 minutes. For sham operations, an anterior gastrostomy and a 
jejunostomy with subsequent closures were performed. One single sham procedure 
lasted approximately 30 minutes. The abdominal wall and the skin were closed in layers 
after both operations. 
2.3 DNA isolation 
The content of intestinal tracts (N= 6-8 per group) collected immediately after euthanasia 
was stored at −80°C (biliopancreatic limb, alimentary limb, common channel, caecum 
and colon after RYGB and in the anatomically corresponding segments after sham 
surgery). 
Metagenomic DNA was extracted from the intestinal content using a QIAamp-DNA stool 
minikit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. 
2.4 qPCR: primers and conditions 
The primers and probes used to detect Total bacteria, Bifidobacterium spp, Lactobacillus 
spp and Bacteroides-Prevotella spp. were based on 16S rRNA gene sequences and as 
described by Vincent et al. [14, 15]. Detection was achieved with a STEP one PLUS 
instrument and software (Applied Biosystems, Foster City, CA) using MESA FAST 
quantitative PCR MasterMix Plus for SYBR Assay (Eurogentec, Verviers, Belgium). 
Each assay was performed in duplicate in the same run. The cycle threshold of each 
sample was then compared to a standard curve (performed in triplicate) made by diluting 
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genomic DNA (five-fold serial dilution) (BCCM/LMG, Ghent, Belgium). The statistical 
analysis was done on logarithmic values. 
2.5 DDP IV activity 
Snap frozen intestinal tissue samples (200 mg) were homogenized in 1 mL cold 
homogenization buffer (10 mM Tris-HCl, pH 8.2), and analyzed immediately for enzyme 
activity. The serum from blood samples was separated by centrifugation and stored at -
20°C until analysis of enzyme activity. 
Determination of intestinal and serum dipeptidyl peptidase-IV (DPP IV) activities, which 
degrades gut peptides like GLP-1, was performed as described by Kreisel et al. [16]. 
DPP IV activities were determined by measuring the release of 4-nitroaniline from an 
assay mixture containing 0.1 mol Tris-HCl (pH 8.0), 2mmol Gly-Pro p-nitroanilide 
(Sigma-Aldrich, Saint Louis MO, USA) as the substrate and enzyme in a total volume of 
0.20 mL. After 30 minutes of incubation at 37°C, the reaction was stopped by the 
addition of 0.4 mL of 2 M sodium acetate buffer (pH 4.5). Human recombinant DPP IV 
(Sigma-Aldrich, Saint Louis MO, USA) was used as standard. The absorbance at 405 
nm was measured by use of a Lab Systems Multiskan RC 96-well plate reader (Thermo 
Fisher Scientific, Waltham MA, USA). All reactions were performed in duplicate. 
Protein concentrations in homogenates were determined according to the method of 
Pierce [17]. Enzyme activities in homogenates were expressed as international units per 
gram of protein, and in serum as international units per liter of serum. One unit 
corresponds to the hydrolysis of 1 mmol of substrate per minute under the assay 
conditions. 
2.6 Statistical Analyses 
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Results are presented as mean ± S.E.M. Statistical significance of difference between 
groups was assessed by Mann Whitney non parametric t-test (Graph-Pad Prism 
Software, San Diego, CA, USA; www.graphpad.com).  
3 Results and Discussion 
Average presurgical body weight of rats was 430 ± 4 g. Seven days after surgery, sham-
operated controls weighed significantly more compared with gastric bypass rats (sham: 
370 ± 9 g vs. bypass: 450 ± 6 g, P < 0.001). Body weight changes for both groups are 
shown in Fig. 2. 
Total bacteria content was significantly increased in the alimentary limb and common 
channel after RYGB compared to sham rats. In the caecum after RYGB the changes in 
the microbial ecology were similar to that seen after prebiotic treatment [4], with 
Bifidobacterium spp and Lactobacillus spp significantly lower. RYGB also increased 
Bifidobacterium spp and Bacteroides-Prevotella spp in the common channel, the 
alimentary limb and in the colon (Fig. 3). After RYGB surgery, DPP IV activity was 
decreased by 27% in the alimentary limb (p = 0.01) and by 32% in serum (p = 0.002) 
(Fig. 4). 
Most changes in microbial composition seen in the RYGB rats were body weight-
independent. In fact, sham-operated body weight-matched rats did not show significant 
modification of gut microbiota compared to ad libitum fed sham-operated controls, with 
the exception for the increase in Bacteroides Prevotella spp. in the alimentary limb and 
the common channel of the body-weight matched rats (data not shown). Although 
changes in gut microbiota seen after RYGB resembled those obtained after weight loss 
in obese rodents [5], our data indicate that RYGB may have specific effects on intestinal 
microbiota. 
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The major finding of the study is that the most substantial shifts in the composition of the 
microbiota were observed in the alimentary limb and the common channel. Interestingly, 
we recently found that the total gene expression of the gut hormones preproglucagon, 
peptide YY and cholecystokinin was increased in the alimentary limb and common 
channel of RYGB rats but not in sham-operated rats that were body weight-matched to 
the RYGB rats [18]. 
Our findings suggest that the bypass of the proximal intestine may contribute to the 
changes of the gut microbiota observed after RYGB. The exclusion of the proximal 
intestine from contact with ingested nutrients has been demonstrated to play a major 
role in the beneficial effects of RYGB surgery [19]. Although a putative mechanism 
promoting such beneficial effects of the surgery remains to be elucidated, our data 
suggest a possible role for changes in the microbial composition of the proximal small 
bowel. 
In the present study, a decreased activity of intestinal and serum DDP IV activity was 
detected. A direct link between the decreased DPP IV activity and changes in gut 
microbiota composition was not investigated; however, we have previously shown that 
prebiotic-induced changes in gut microbiota and increased GLP-1 levels were 
associated with reduced DPP IV activity [20]. The gut microbiota changes that we 
observed in this study resemble in part those seen after treatment with prebiotics, thus 
we think that similar mechanisms may have prevailed under the conditions of our study.  
The modest decrease in serum DPP IV activity in response to RYGB compared to 
pharmacological approaches is consistent with other studies in humans [21]. It could be 
secondary to the experimental conditions; it is e.g. known that the diabetic status may 
influence the level of DPP4 activity [22]. In our RYGB model, however, the difference of 
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glucose tolerance between sham-operated and RYGB is not supposed to differ as much 
as in some models of obesity and type 2 diabetes frequently used to test 
pharmacological approaches. Hence, we expected the difference of DPP-4 activity in our 
study to be smaller. 
Further, because DPP-4 is mainly a tissue enzyme, changes in serum DPP-4 activity 
may not completely reflect the total decrease in activity of the enzyme and the 
consequent decreased inactivation of incretins. In the present study, DPP-4 activity in 
the alimentary limb was also decreased and might explain the robust increase in 
circulating incretin levels usually detected in our RYGB rat model [1]. In other words, 
reduced intestinal and serum DDP IV activity may contribute to enhanced bioavailability 
of endogenous GLP-1 and be consistent with the modulation of jejunal microbiota 
altering the production or breakdown of gastrointestinal hormones known to control 
energy balance. 
4 Conclusions  
In conclusion, these data are critical because they accurately represent how RYGB 
surgery may affect microbial communities in different intestinal segments after surgery. 
Because most changes in gut microbiota were independent from weight loss, we 
conclude that other mechanisms than weight loss per se seem to be responsible for the 
alteration of the intestinal microbial population after RYGB surgery. 
Postsurgical modulations of the gastrointestinal microbial community, e.g. the bypass of 
the intestinal foregut, may influence gut peptide synthesis, release and breakdown; 
hence, these changes may significantly contribute to the beneficial metabolic effects of 
RYGB surgery independent of the RYGB-induced body weight loss. 
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The impact of RYGB on the microbiota of the different intestinal tracts remains to be 
confirmed in other experimental models, e.g. in a high fat diet or a genetic model of 
obesity, and in large-scale studies including body weight-matched controls and using 
pyrosequencing, metagenomic analysis and metabolic profiling. These tools will enable 
further insight into the composition of the intestinal microbiota and its functional evolution 
after bariatric surgery. Elucidating the mechanisms by which gut microbiota interact with 
the host will provide a new basis for putative pharmacological or dietary intervention for 
obesity and its related comorbidities. 
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Figure captions 
Figure 1:  
Schematic illustration of the surgical diagram of our animal model of RYGB  
A: Normal gut anatomy    B: Gut anatomy after RYGB surgery: 
            1: biliopancreatic limb/duodenum 
            2: alimentary limb/proximal jejunum 
            3: common channel/distal jejunum 
            4: caecum   
Figure 2: 
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Body weight change for the gastric bypass (-●-) (n = 8) and sham-operated rats ad 
libitum fed (-○-) (n = 8). Data are expressed as mean ± SD. 
Figure 3:  
RYGB-associated changes in gut microbiota. 
Results are given as the Log10 of bacteria/intestinal content (g). Data are expressed as 
mean ± S.E.M * p < 0.05; ** p< 0.01; *** p< 0.001 compared to sham-operated rats. 
Figure 4:  
RYGB-associated changes in DPP 4 activity. Data are expressed as mean ± S.E.M * p < 
0.05; ** p< 0.01 compared to sham-operated rats. 
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